Found: 19
Select item for more details and to access through your institution.
Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda.
- Published in:
- Oxford Medical Case Reports, 2020, v. 20, n. 6, p. 1, doi. 10.1093/omcr/omz121
- By:
- Publication type:
- Article
Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda.
- Published in:
- Oxford Medical Case Reports, 2019, v. 2019, n. 2, p. N.PAG, doi. 10.1093/omcr/omy132
- By:
- Publication type:
- Article
Boosted lopinavir vs boosted atazanavir in patients failing a NNRTI first line regimen in an urban clinic in Kampala.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19792
- By:
- Publication type:
- Article
Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda.
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00615-6
- By:
- Publication type:
- Article
Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-023-00564-6
- By:
- Publication type:
- Article
Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-023-00510-6
- By:
- Publication type:
- Article
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 9, p. 2079, doi. 10.1111/bcp.16154
- By:
- Publication type:
- Article
Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda.
- Published in:
- 2022
- By:
- Publication type:
- journal article
An Interactive Voice Response Software to Improve the Quality of Life of People Living With HIV in Uganda: Randomized Controlled Trial.
- Published in:
- Journal of Medical Internet Research, 2021, v. 23, n. 2, p. N.PAG, doi. 10.2196/22229
- By:
- Publication type:
- Article
Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09655-9
- By:
- Publication type:
- Article
Prevalence of overweight and obesity and associated factors among people living with HIV attending a tertiary care clinic in Uganda.
- Published in:
- BMC Nutrition, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40795-022-00604-w
- By:
- Publication type:
- Article
High willingness to use injectable antiretroviral therapy among women who have been lost to follow‐up from HIV programmes: A nested cross‐sectional study.
- Published in:
- HIV Medicine, 2022, v. 23, n. 4, p. 319, doi. 10.1111/hiv.13260
- By:
- Publication type:
- Article
RISK FACTORS FOR ADRS RELATED TO IPT AMONG PLHIV ON DOLUTEGRAVIR-BASED ART IN UGANDA.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 296
- By:
- Publication type:
- Article
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The burden of drug resistant tuberculosis in a predominantly nomadic population in Uganda: a mixed methods study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2018, v. 73, n. 11, p. 3158, doi. 10.1093/jac/dky298
- By:
- Publication type:
- Article
High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Potential Teratogenicity Alert for Women Conceiving on Dolutegravir-Based Regimens: An Assessment of Risk Communication by an Urban HIV Clinic in Uganda and Choices made by Women.
- Published in:
- Drug Safety, 2020, v. 43, n. 11, p. 1133, doi. 10.1007/s40264-020-00974-9
- By:
- Publication type:
- Article